In humans, the gastrointestinal tract has evolved to absorb whole proteins. In abnormal states, nutritional support in the form of particles smaller than protein size compensates for abnormalities in the intestinal mucosa and for pancreatic insufficiency. The use of peptides or amino acid mixtures is suggested as a way of improving digestive tolerance and efficiency of metabolic utilization.
In humans, the gastrointestinal tract has evolved to absorb whole proteins. In abnormal states, nutritional support in the form of particles smaller than protein size compensates for abnormalities in the intestinal mucosa and for pancreatic insufficiency. The use of peptides or amino acid mixtures is suggested as a way of improving digestive tolerance and efficiency of metabolic utilization.
Our aim in this chapter is to review tolerance and utilization of enteral nitrogen and to outline the clinical benefits and disadvantages of proteins, peptides, and amino acid solutions. The terms polymeric, oligomeric, and monomeric solutions will be used, instead of protein-based, peptide-based, and elemental solutions.
Normal Physiology
Nutrient absorption occurs progressively throughout the small bowel. Chyme protein absorption takes place mostly above the ileum (Fig. 1) . Gastric pepsin initiates the digestion process of proteins by splitting proteins into peptides. Pancreatic juice is stimulated to flow in response to increases in the blood concentrations of two gastrointestinal hormones, secretin and cholecystokinin. Several enzymes (carboxypeptidase, chymotrypsin, and trypsin) secreted in inactive form in pancreatic juice are liberated and break peptide linkages in protein molecules. In addition, a range of brush border membrane peptidases (including aminopeptidase, dipeptidyl aminopeptidase, and amino-oligopeptidases) hydrolyze oligopeptides of up to eight amino acid residues. Absorption of luminal amino acids into the portal circulation involves transport across the brush border membrane, diffusion through the enterocyte cytoplasm, and transport across the basolateral membrane. Brush border transport of amino acids occurs by a combination of simple diffusion, facilitated diffusion, and active transport; of these, active transport is quantitatively the most important. Comparison of casein and lactalbumin showed that β-lactoglobulin emptied from the stomach as rapidly as water, was poorly digested in the stomach (unlike casein), and appeared in the duodenum as undigested protein; however, absorption of constituent amino acids of both proteins was similar, and this reflected the efficiency of luminal and brush border digestion [1] .
Several hours after protein meals in man and experimental animals, the bulk of the digested material in the lumen of the small intestine is a complex mixture of peptides and free amino acids. Abidi and Mercer [2] showed that 30 min to 4 h after a meal containing 50 g of bovine serum albumin, the peptide-bound amino acid fraction was much greater than the free amino acid fraction both in the jejunum and proximal ileum. Adibi [3] also showed that the rate of amino acid absorption was significantly faster from dipeptide and tripeptide solutions than from corresponding amino acid solutions. The rate of disappearance of peptides in the jejunum and ileum is similar, or only slightly different, whereas that of free amino acids is much slower in the ileum than in the jejunum [4] . The mechanism of the greater efficiency of peptide absorption in the ileum seems to be a greater capacity for transport of peptides than amino acids. Gropper and Acosta [5] found that plasma amino acid concentrations peaked 30 min after ingestion of amino acids alone and after whole protein, whereas plasma amino acid peaks appeared 150 min after ingestion of whole proteins. The effect of rapidly peaking plasma amino acid concentrations on protein synthesis is unclear.
Intestinal transit time affects the absorption of all nutrients, including proteins and amino acids. Bowling and Silk [6] reviewed the intestinal responses induced by enteral feeds. During postpyloric feeding, normal postprandial small intestinal motility patterns occurred and the colonic inflow volumes increased from the fasting state. During intragastric feeding, both motility and inflow volumes remained similar to those observed during the fasting state. Receptors controlling the small intestinal responses to diet, which appear to be located in the proximal small intestine, may explain why foods infused directly into the duodenum are able to initiate the fed response, whereas the same rate of infusion into the stomach -which releases its contents gradually through the pylorus -is insufficient to initiate normal postprandial responses. Thus it appears that the small intestine responds predictably to enteral feeding, both in terms of motility and fluid movement, regardless of the site of diet infusion. In studies by Raimundo et al. [7] , it was noted that subjects fed intragastrically developed diarrhea, whereas those fed intraduodenally did not. It was suggested that enteral feedingrelated diarrhea in patients with a normal bowel may occur as a result of disordered colonic function rather than small bowel dysfunction.
The ascending colonic secretion is of fundamental importance to the pathogenesis of enteral feeding-related diarrhea. The increased colonic load resulting from the colonic secretion may be the result of various neural and humoral responses which affect colonic motor activity and motility. Receptors controlling the colonic response to feeding are located both in the stomach and the duodenum. Colonic secretion is seen during intragastric feeding but not during intraduodenal infusion of low-load diets (2000 kcal and 2 liters/day). However, both the motor activity and fluid transport were more affected by high load diets (6000 kcal and 4 liters/day) when given intragastrically. Chemoreceptors in the duodenum and proximal jejunum respond to osmolality, fat, glucose, and protein, and distention has been shown to be an effective stimulus of colonic secretion.
Tolerance of enteral feeding depends on several factors, including functional capacity of the gastrointestinal tract, the rate of infusion, the type of formula used, and any concomitant drug treatment. The healthy gastrointestinal tract can easily handle bolus feeds as large as 500 ml given over 10-20 min. Patients with gastrointestinal diseases may require a slower rate of infusion (<100 ml/h). Water is absorbed passively throughout the intestine (Fig. 2 ) and is regulated primarily by active electrolyte absorption. Studies in healthy volunteers have shown that significant colonic secretion of water, sodium, and chloride occurs during enteral feeding [8] . This may contribute to diarrhea, especially in patients with compromised intestinal function. The beneficial effects of fiber in enteral feed-related diarrhea appear to reflect the important role played by short-chain fatty acids in salt and water absorption in the ascending colon [6] .
In enteral nutrition, the advantage of using oligopeptides versus amino acids as substrate in enteral nutrition (Table 1) is that they reduce the hypertonicity of the solution, and allow the provision of amino acids that are either poorly soluble in water (for example, tyrosine) or unstable in free form (for example, glutamine and cysteine) [9] . aims to minimize the clinical symptoms and optimize nutrient absorption. A decreased capacity for absorption or digestion in illness (such as cystic fibrosis, pancreatic insufficiency, short bowel syndrome, and AIDS) may require adaptation of nitrogen source. The use of monomeric nutrient solutions was thought to allow bowel rest and the removal of antigens and to improve nutrition [10] . Monomeric and oligomeric solutions were found to be equally effective in achieving clinical remission [11] and reducing intestinal inflammation in Crohn's disease [10, 11] . A study of Crohn's disease patients showed significantly less mucosal inflammation (as measured by α 1 -antitrypsin clearance) in a group receiving oligomeric compared with one receiving polymeric formulas.
Additional considerations influencing the choice of protein in illness are absorption and utilization. In patients with 60-150 cm of jejunum remaining, protein and partially hydrolyzed protein were equally well absorbed [12] . When the absorptive area was more severely reduced (50-80 cm jejunum), no difference was observed in nitrogen balance, nitrogen absorption, or leucine kinetics when patients received a whey protein hydrolysate-based or equivalent amino acid-based enteral diet [13] . However, free amino acid absorption may be limited by saturation of the transport system for free amino acids, which share the same carrier. Enhanced amino acid absorption rates from dipeptide, in comparison with free amino acid mixtures, appears to reflect a greater capacity for transporting peptides than amino acids [14] . In patients with celiac sprue, the jejunal absorption rate of free amino acids was markedly reduced [15] . This unequal impairment allowed greater amino acid transport through dipeptide than free amino acid absorptive pathways.
It has also been shown that polymeric, oligomeric, and monomeric enteral nutrition formulas (Ensure HN  , Criticare HN  , RTF Elemental  , respectively) cause significant stimulation of pancreatic proteolytic enzyme secretion. The polymeric formula had a stronger stimulatory effect than the oligomeric or elemental formulas on pancreatic enzyme secretion [16] .
Steinhardt et al. [17] found that oligopeptide, in the form of lactalbumin hydrolysate, resulted in 91% absorption in pancreatectomized subjects, vs. 61% absorption of whole lactalbumin in the same subjects. Similarly, Ehrlein and Haas-Deppe [18] found decreased absorption of oligomeric and polymeric formulas in the absence of pancreatic enzyme supplementation, and a significant increase with exogenous enzymes. There appears to be no advantage to oligomeric formulas in subjects with normal pancreatic secretion. On the other hand, in an animal model with reduced pancreatic secretion, polymeric formulas with added enzymes, or completely hydrolyzed hyperosmotic oligomeric formulas, are generally recommended [18] .
The persistence of a stimulus for biliary and pancreatic secretion in patients fed into the jejunum may explain why most patients fed distally are able to absorb a polymeric diet adequately and do not require predigested nutrients [19] . This also implies that complete inhibition of biliary and pancreatic secretions probably cannot be expected during jejunal feeding. Administration rate Osmolality Degree of protein, fat and carbohydrate hydrolysis 
Tolerance
In this review, the term 'tolerance' is used with respect to clinical symptoms, such as gastric residue, vomiting, and diarrhea, that are directly related to the administration of enteral nutrition solutions with different protein sources and osmolalities (Fig. 3) .
In healthy volunteers, no diarrhea was apparent until the rates of feeding nutrient solutions exceeded 267 ml/h, representing a mean 7450 kcal/day, 952 g/day carbohydrates, 260 g/day fat, and 318 g/day protein [20] , suggesting tolerance of large quantities of nutrient solution in the absence of disease.
Major differences in the definition and method of reporting diarrhea significantly influenced the reported extent of diarrhea in tube-fed patients [21] and make it difficult to compare tolerance data in different studies. Heimburger et al. [22] defined diarrhea as more than 200 g of stool a day on 2 consecutive days, or if stool collection is incomplete, more than three liquid stools a day. Others have defined diarrhea as more than 300 g of stool a day. Allowing for the limitation imposed by the lack of a clear definition, similar rates of diarrhea were noted with peptides and whole proteins. Heimburger et al. [22] found that diarrhea days were no greater with peptide solution (18.7%) than with whole protein solution (17.3%), despite differences in the osmolality of the solutions: 490 mosm/l vs. 330 mosm/kg for peptide and whole protein solutions.
Rees et al. [23] found no differences in mean stool output (110 š 49 vs. 111 š 32 g/day) between peptides (Reabilan  ) and polymeric formulas (Clinifeed  ), respectively, in malnourished patients with varying gastrointestinal abnormalities such as Crohn's disease, resolving pancreatitis, and small bowel resection. However, one patient with jejunal diverticulosis was relatively intolerant of the Tolerance and Utilization of Enteral Nitrogen polymeric diet. Differences in formula other than the protein source (that is, fat and/or sugar content or type) could also have influenced formula tolerance.
A higher incidence of diarrhea in a group given a small peptide formula resulted from the coincidental use of more diarrhea-causing drugs [24] . Only one case was attributed to tube feeding. Heimburger et al. [25] noted that diarrhea occurred more often in tube-fed patients who had low serum albumin levels and had been treated with antibiotics for long periods, but these associations are generally not causal. Most cases of diarrhea were connected with factors not related to tube feeding.
Meredith et al. [26] noted less diarrhea with peptides than with whole proteins (0% or no patients vs. 44% or four patients) in trauma patients, despite the fact that the peptide formula had a higher osmolality than the polymeric formula (490 vs. 310 mosm/kg). Velasco et al. [27] reported no diarrhea on post-surgery days 2 and 3 with oligomeric and monomeric solutions in elective gynecological surgery, despite osmolalities of 764 and 874 mosm/kg of peptide and amino acid solutions, respectively. Feller et al. [28] compared tolerance to polymeric formula with tolerance to oligomeric and monomeric formulas in elderly patients (>60 years old) and found no differences in nausea, diarrhea, or abdominal distention, and similar numbers of bowel movements (one to two stools a day) with all three formulas, despite considerable differences in osmolality (260-300 vs. 630 mosm/kg). Kemen et al. [29] also found no difference in gastrointestinal intolerance in intensive care unit (ICU) patients after surgery for upper gastrointestinal malignancies with Impacts versus placebo formula (both whole protein), despite differences in osmolarity (293 vs. 486 mosm/kg, respectively). These studies suggest that hypertonic formulas are not associated with increased rates of diarrhea.
After adjustment for the use of antibiotics, there were no significant differences in the numbers of bowel movements, vomiting, and high residuals between soy protein hydrolysate and casein-based formula (Osmolite  ) in elderly general surgery patients without gastric or intestinal symptoms before study, and without recent abdominal surgery or trauma [30] .
Timing and Mode of Administration
The timing and rate of enteral nutritional support influence the gastrointestinal tolerance of enteral nutrition. With oligomeric solution, symptoms of gastrointestinal intolerance required a mean reduction in feeding rate of 52% on postoperative days 4-6 compared with days 2-3 in patients undergoing major abdominal surgery. Thus gastrointestinal intolerance did not occur during the period of postoperative ileus but rather during a 2-to 3-day period following the return of bowel sounds [31] . Early postoperative enteral nutrition, defined as Ä 72 h after surgery or trauma, by nasojejunal tube was possible in 75% of patients. Intake was 1179 š 388 kcal/day in the enteral group vs. 382 š 71 kcal/day in a control group p < 0.0001 . There was a significantly greater accumulation of hydroxyproline, but no difference in the amount or composition of weight change, muscle function, or postoperative fatigue. Early postoperative nutritional support was only recommended in subjects who were malnourished and in whom postoperative problems were anticipated [32] . Pichard and Roulet [33] found less abdominal distention and gastric discomfort, and tolerance of higher quantities of enteral nutrition, with continuous versus fractioned tube feeding in head and neck cancer patients, suggesting better tolerance of continuous infusion feeding than bolus feeding. Studies in healthy volunteers showed that significant colonic secretion of water, sodium, and chloride occurs during enteral feeding [8] . This may contribute to diarrhea, especially in patients with compromised intestinal function. Tolerance in these patients can be improved with continuous infusion of solutions at Ä 100-150 ml/h.
Endogenous Factors Affecting Tolerance
Brinson and Kolts [34] suggested that hypoalbuminemia in ICU patients with multiple organ failure was one of the factors responsible for an increased incidence of diarrhea with enteral nutrition and that peptide-based formulas could improve enteral nutrition tolerance. Patterson et al. [35] did not find a statistically significant difference in enteral nutrition tolerance and diarrhea incidence between patients with serum albumin < or > 25 g/l in a metabolic support unit. Mowatt-Larssen et al. [36] found no significant difference in the incidence of diarrhea between critically ill patients fed oligomeric and polymeric formulas, nor was there a significant difference in the incidence of diarrhea in patients with serum albumin concentrations of <25 g/l.
In summary, there appears to be little difference in tolerance of polymeric and oligomeric formulas despite differences in protein source or form and osmolarity, and tube feeding intolerance is often related to factors other than nutrient solution. Indications for nutrient solutions are shown in Table 2 .
Tolerance and Utilization of Enteral Nitrogen

Efficiency
In addition to tolerance, protein efficiency must also be considered in the evaluation of proteins, peptides, and amino acids as sources of nitrogen. In this review 'efficiency' will be discussed in terms of absorption and digestion of protein sources and their effects on nitrogen metabolism and serum proteins. Protein efficiency depends on protein source and is limited by the amino acid composition and protein form (whole protein vs. hydrolysate vs. amino acid) [37] .
Nitrogen retention in animals fed protein hydrolysates was greater than in those fed whole proteins [38] . In contrast, no difference in terms of nitrogen balance was detected in other human [39] and animal studies [40] . Soy protein hydrolysate formula produced a similar nitrogen retention per gram nitrogen intake to a casein-based formula (Osmolite  ) [30] . In malnourished patients with gastrointestinal abnormalities such as Crohn's disease, resolving pancreatitis, and small bowel resection, Rees et al. [23] found no differences in nitrogen balance with peptides versus polymeric formulas (C1.0 g peptides (Reabilan  ) vs. C0.6 g polymeric (Clinifeed  ), respectively) and concluded that there was no nutritional advantage in feeding peptides. Net absorption was better with peptides in patients with small intestinal mucosal defects and significant clinical malabsorption. In patients with small bowel disease (jejunal diverticulosis, amyloidosis, and ileocolonic Crohn's disease), intestinal mucosal absorptive reserve capacity may to be sufficiently impaired for the oligopeptide nitrogen source to have a nutritional advantage over whole protein [23] . Energy and nitrogen utilization was equal and resulted in comparable increases in fat-free mass and fat mass in Crohn's disease with two different peptide solutions that contained different fit contents [41] .
Serum prealbumin and fibronectin, reflecting visceral protein synthesis, increased in both the whole protein and peptide groups, but the increase was significant only in the small peptide group. Small peptide diets produced slightly greater increases in serum rapid synthesis proteins than whole protein diets [24] . The clinical implications of this difference between diets are unknown.
Although short peptides stimulate protein synthesis, in practice they result in similar nitrogen balance because of higher oxidation of peptide-derived than protein-derived leucine. Protein hydrolysate diets were found to cause smaller urinary nitrogen losses than diets containing whole protein. Boza et al. [42] speculated that faster absorption from peptides resulted in increased protein synthesis, mainly in the enterocyte cells. No difference was found in serum amino acids with both whole protein or hydrolysate formula. Despite higher nitrogen retention in enzyme hydrolysates, no difference was noted in amino acid concentration or nonessential to essential amino add ratios [42] . Grimble [1] suggested that the positive effects of peptide formulas, compared with whole protein or amino acids, may result from: (i) more rapid amino absorption with peptide formulas, leading to enhanced insulinemia [43] ; (ii) subtle differences in composition between hydrolysate and control solutions [43] , or (iii) the presence of bioactive peptides released during the hydrolysis of milk protein (for example, antithrombotic κ-casein glycopeptide) [44] .
Splanchnic extraction was greater for protein than for peptides in postgastrointestinal surgery patients, indicating that dietary leucine (and probably other amino acids as well) is more bioavailable in the periphery when derived from very short-chain peptides than from whole protein. However, increased oxidation compensated for this better peripheral delivery, resulting in identical leucine balance (synthesis minus breakdown) with the two substrates [45] .
In burn patients, an amino acid solution normalized the plasma amino acid profile and the serum concentration of amino acids, but did not change muscle protein catabolism. Peptides decreased the 3-methylhistidine to urinary creatinine ratio, which suggests decreased muscle catabolism, but caused no improvement in plasma amino acids or serum proteins [46] . Nitrogen was more efficiently used with whole protein than with peptide solutions, and whole protein diets resulted in less weight loss, more protein in the liver, and less fat tissue loss. No effect on inflammation-induced changes in muscle ubiquitin was noted [47] . Although changes in nitrogen balance were significant from day 1 to day 10 in each group, and at day 10 between groups (peptide (Reabilan  ) -14.3 vs. -3.2 g for standard formula (Isocal  )), no advantages of peptide formula over standard formula were noted. Plasma prealbumin, but not the albumin concentration, increased significantly from day 1 to day 10 post-burn in both groups [36] n D 41 .
Meredith et al. [26] found significantly higher prealbumin, transferrin, and albumin concentrations with peptides compared with polymeric formulas in trauma patients after one week of tube feeding.
Feller et al. [28] compared polymeric (Isocal  ), oligomeric (Peptamen  ), and monomeric (Vivonex HN  ) formulas in elderly patients (>60 years old) with intact gastrointestinal tracts and found better biological values with polymeric and oligomeric than with monomeric solutions. They noted a significant decrease in retinol-binding protein, albumin, transferrin, and cholesterol after 4 weeks of feeding when the formula was changed from polymeric to monomeric; a significant increase when changing from monomeric to oligomeric, and no change from polymeric to oligomeric formula (Table 3) . They found that blood urea nitrogen concentrations decreased when the monomeric formula was used. They suggested that old age might alter the absorption or metabolism of free amino acids. Possible causes for this could be: bacterial colonization of the small intestine, causing reduced absorption of free amino acids, diminished enzymatic and proliferative capacity of the small intestinal mucosa, or impaired renal tubular conservation of circulating amino acids during postprandial hyperaminoacidemia following rapid absorption of ingested free amino acids in frail elderly people [28] .
Ziegler et al.
[48] found better restoration of plasma amino acid and protein levels with oligomeric formulas than with whole proteins in ICU patients after gastrointestinal surgery for cancer, peritonitis, and abdominal bullet wounds. Table 3 . Changes in serum albumin, transferrin and cholesterol in tube-fed elderly patients with intact gastrointestinal tract after modification of enteral nutrition (polymeric, oligomeric or monomeric nutrient solutions)
Albumin
Transferrin Cholesterol
Polymeric to oligomeric
Adapted from Feller et al. [28] .
Nitrogen balance, however, was not significantly different between the two diets. The administration of protein hydrolysate tended to reduce urinary nitrogen losses, whereas non-degraded protein improved nitrogen retention in the small bowel. Svanberg et al. [49] suggested that nutrients are the major factor stimulating protein synthesis in muscle during refeeding, and that other factors are quantitatively less important. Their results showed that incomplete diets only partially restored the synthesis of mixed muscle proteins and that a complete mix of dietary components was necessary for maximum activation of protein synthesis and for initiating the translation of both soluble and myofibrillar proteins in skeletal muscle. An amino acid imbalance between different test diets could be an important factor explaining the different effects of peptide and whole protein diets compared with amino acids. In animals (healthy pigs), uptake and metabolism of free hydrolysate amino acids and whole protein did not differ when the amino add composition was identical [50] .
In summary, utilization of a nitrogen source is better with polymeric and oligomeric nutrition solutions than with monomeric solutions. Better restoration of plasma amino acids and serum proteins is found with monomeric formulas than with whole proteins, but muscle protein catabolism remains unchanged. Peptides decrease muscle catabolism, but produce no improvement in plasma amino acids or serum proteins [46] . Nitrogen is more efficiently utilized with whole protein than with peptide solutions, and whole protein diets result in less weight loss, more protein in the liver, and less fat tissue loss [47] . Monomeric nutrient solutions are rarely necessary or justified in small children and almost never in adult therapy.
Strategies for Nitrogen Source Utilization in Enteral Nutrition
Successful use of enteral nutrition solution in disease is influenced by various factors. Many of these are not related to their amino acid, peptide, and protein content, but are related to intestinal transit time, gut mucosa status, gastrointestinal secretions, bacterial flora, hormone profiles, rate of administration, other nonprotein components (such as carbohydrate and fat) of the nutrition solution and treatments (such as chemotherapy and surgery). In addition, physical activity and muscle tone also influence gastrointestinal activity. It is, therefore, difficult to study the effects of unequal nitrogen sources because of the combined effects of protein and other factors. Quite often, tolerance or lack of tolerance of enteral nutrition in disease is multifactorial and may be a cause as well as a consequence.
During recovery from illness, nutrition support must be considered at a time when the function of the gastrointestinal tract is necessarily affected. Does protein particle size influence tolerance and improve the efficiency of the nitrogen source and affect the outcome of nutritional support?
From a theoretical point of view, it should be possible to treat each failure of a specific digestion-related function (for example, pancreatic insufficiency) with a corresponding modification of nutrient composition. However, published reports provide poor support for this theory. From a clinical point of view there appears to be little benefit in using peptides or amino acids over whole protein solutions. Recent studies suggest that polymeric solutions are effective in terms of tolerance and efficiency in patients who do not have seriously compromised intestinal tracts and in those with limited pancreatic function, as long as pancreatic enzymes are given at the same time. Polymeric solutions are well tolerated in subjects with mildly compromised intestinal tracts and when a minimum of 80-150 cm of small intestine is remaining. In patients with seriously impaired gastrointestinal function, the functional reserve of the gastrointestinal tract for absorption of intact proteins may be sufficient for satisfactory assimilation of whole proteins [23] . In patients with significant small intestinal mucosa defects and major clinical malabsorption (for example, ileocolonic Crohn's disease, gluten enteropathy), oligomeric formulas can offer nutritional advantages over whole proteins. Monomeric nutrient solutions are infrequently necessary or justified in small children, and almost never in adults.
Conclusions
A review of published reports suggests that the level of protein hydrolysis of enteral solutions has little impact on clinical tolerance and metabolic efficiency. This contrasts with the theoretical concept that each specific digestive dysfunction should be treated with a specifically designed enteral nitrogen source. From a practical point of view, the critical factor which influences the assessment of protein efficiency in various disease states is global tolerance of nutrient solutions and related treatment. Because of the large variability in patient tolerance and many other confounding factors, it is difficult to make a clear assessment of protein metabolism and utilization. Overcoming this methodological problem will allow the development of new protein sources for use in enteral nutritional support which may, in the future, allow us to tailor and optimize nutritional treatment for various disease states. 
Discussion
Dr. Bentsen: Emphasizing the use of whole protein diets is correct in many situations, but I'm concerned that we shouldn't extrapolate all your adult findings to young infants and neonates. They are quite a different group where you have problems with oral tolerance, or with the lack of development of oral tolerance. You also cited the study by Burns on 10 short bowel adult patients. I think that's an example of how you probably shouldn't do a study, because they did three different things simultaneously. They introduced an enteral polymeric diet, which could have an effect; they gave growth hormone, which could have an effect, and they also gave glutamine, which could have an effect as well. So we can't tell what is working. Then I believe that most of the patients had inflammatory bowel disease and thus the use of glutamine might have been inadvisable.
Dr. Pichard: I agree about children, maybe even teenagers. Regarding glutamine and its use in patients with inflammatory disease: if you go into any hospital throughout the world, you will quickly realize that almost half the patients have inflammation. If you deny these patients glutamine you will diminish its application considerably.
Dr. Boza: You referred to the rat data from Zarrabian et al. [1] . During my PhD work I did studies on another rat model where the rats were starved for 3 days, and I found just the opposite to Zarrabian et al.: in the first 2 days there was a better nitrogen retention with protein hydrolysate [2] . I think we should be careful about extrapolating for such studies. It seems to me that when patients who have been on long-term total parenteral nutrition start changing to enteral nutrition, protein hydrolysate diets would perhaps be better than intact protein diets.
Dr. Pichard: I only mentioned that study to show that when you analyze your data, or when you design your study, it's quite difficult to know when to do the measurements, because the situation is dynamic. I wasn't implying that we should use whole protein diets in inflammatory bowel disease.
Dr. Roessle: You very correctly pointed out that the level of intake of energy and protein is probably the major determinant of outcome. Now for technical and pragmatic reasons it is difficult to make protein-rich, energy-dense feeds because protein enhances the viscosity of the feed. This can easily be overcome by hydrolyzing the proteins, which will lead to fewer problems with tube clotting. So if you want to give a very high protein intake, peptide diets might be preferable. I would, rather provocatively, like to ask you whether you see any problem in using slightly hydrolyzed protein rather than intact protein in a standard tube feeding diet.
Dr. Pichard: There should be no problem. Dr. Silk: I agree very much with your point that what is prescribed in the terms of enteral feeding is not necessarily actually given, if you prospectively audit the treatment charts. We did this in my unit, and the results were astounding: I think the best was 60% of the intended intake. I don't think you have to change the composition of the diet to overcome that problem. All you have to do is train the nursing staff to keep a closer eye on the rate at which the infusions are given.
Dr. Pichard: In our hospital we have a large nutritional team looking after about half the patients. We recently finished a survey of about 800 patients who were supposed to benefit from enteral nutrition. The gross daily intake in these patients amounted to 1 g/kg of protein and 17 kcal/kg energy. I still believe this is a very difficult issue.
Dr. Steenhout: What is your view about the management of patients receiving highdose chemotherapy who have complete destruction of the intestinal mucosa?
Dr. Pichard: If the intestinal mucosa is completely destroyed there is no chance of feeding through the gut. However, the time will come when there will be some restoration of the mucosa, and I'm totally convinced that if you have started to stimulate the gut with even a minimal amount of feed you will gain a lot of time. What we generally do is to maintain them on TPN, with some supplemental enteral nutrition, say 200 kcal/24 h, and as soon as we feel they can tolerate more we increase the intake. This is not a scientifically based strategy, but from a clinical point of view it works well.
Dr. Wernerman: There is a great deal of controversy about this, especially in the intensive care setting. You may have to have a feeding tube in the intestine or the stomach, which is a disadvantage, especially if the tube passes the pylorus. Also there is usually gastric retention which causes difficulty. When the concept of early enteral nutrition in surgical patients emerged, it was claimed that if you started feeding very soon after the trauma, gastric retention did not occur. Is this a religious question or is there actually evidence for this?
Dr. Pichard: I think that's a very dogmatic position. All the patients entering our medical or surgical adult ICUs have a nasogastric tube installed immediately, except if they are undergoing any type of resuscitation, and start to receive enteral nutrition. We have found this a lot cheaper and easier than analyzing individually which patients should receive enteral nutrition support. Then the physician in charge of the patient will decide within a few days whether or not the enteral feeding should be continued. This is now our usual strategy, and the nurses and junior doctors are all quite used to giving very early enteral nutrition. I doubt whether delayed gastric emptying precludes the use of enteral nutrition in ICU patients, though some, of course, do not tolerate it. It's not possible to achieve nutritional support using the enteral route for every patient in the ICU, but it is for most of them.
Dr. Haschke: My question is about tolerance of cow's milk protein in adults. It is now believed that so-called intolerance of cow's milk in adults is not only related to lactase deficiency but also to the fact that some adults do not tolerate the cow's milk protein on an immunological basis. In enteral nutrition we generally used cow's milk protein as the main protein source. Do you see problems from cow's milk protein intolerance in your hospital? And if so, in what percentage of the patients? If there is a problem do you then use peptides? Dr. Pichard: I'm not in a very comfortable position here. I believe that enteral nutrition is extremely well tolerated in most patients when you use polymeric diets, but I don't know whether those patients who do not tolerate it have the problem you describe, or whether the lack of tolerance relates to the underlying pathology or treatment.
Dr. Hunter: We've been interested in cow's milk protein intolerance. It's true that double-blind challenges have confirmed that it does exist, but it's very uncommon, less than 5%. It doesn't cause an anaphylactic reaction; it's an intolerance only, not an allergy, so it doesn't cause any dramatic side effects, though it may result in diarrhea or gut upset. In the short term postoperatively, we find that this really doesn't matter very much. Obviously if you have to go on with enteral feeding for longer and you find that the patient has persistent symptoms, you may need to change the feed, but by and large using feeds based on cow's milk protein is not a problem in our experience.
Dr. Grimble: Your regimen seems to be meeting nutritional targets better than before but with an inadequate mode of feeding, i.e., continuous nasoenteral feeding. Do you have any particular views on ways in which you might improve enteral feeding, perhaps by pulsed feeding?
Dr. Pichard: In the past, most hospitals did use pulsed feeding, because the pumps available were non-nutritional, so we had to use either a drip or some kind of pulsed feeding. This tended to be poorly tolerated not only by patients but also by the nurses. With the current closed system, where you have the food container, the tubing, and the connection to the patient in a single set, this situation has improved greatly. We have less nausea, less vomiting, less abdominal distension, and less diarrhea than before, and this involves at least 15 years of clinical experience. I know there are other problems relating to enteral feeding, but I can tell you for certain that quantitatively there has been a great improvement with continuous enteral infusions. If we have problems with intake it is because the patient leaves the ward for some reason or because the feed bags aren't changed when they run out, not because of intolerance.
Dr. Grimble: Campbell et al. [3] , Nacht et al. [4] and Shulman et al. [5] have produced data showing that bolus patterns of meal feeding have quite disproportionate effects on the health of the gut in promoting growth, normal patterns of motility and gastrointestinal hormone secretion. I wonder why there's a certain nervousness about moving towards more adventurous techniques of enteral feeding.
Dr. Pichard: Maybe because we're talking about different targets. For really diseased patients with very poor tolerance to almost anything I think continuous infusions are almost the only way to feed them. But if you are talking about any type of patient during the recovery phase, then I believe we should aim at giving pulsed feeding.
Dr. Millward: A simple question from someone who has no experience at all of managing these sorts of patients: when you find that you're only delivering 0.4 g protein and 17 kcal/kg isn't it an option just to increase the rate of feed delivery? Is that a silly question?
Dr. Pichard: No, it's a good question, but you can't turn it up. Dr. Silk: I think this has been an incredibly helpful talk, because we have spent enjoyable hours discussing the theoretical reasons for including certain substrates, protein peptides, and amino acids in the diet and their metabolic pathways, and now you are explaining so eloquently to this distinguished audience what a shambles it is on the shop floor! This is a very important point. You're the only person that I've heard admitting that you're getting inadequate intakes, but that's how it is in the real world. I agree absolutely with your answer. No, you can't turn it up. Nor do we have enough nursing staff these days, or dietetic staff. These are the confines within which we have to work these days.
Dr. Roessle: From a practical standpoint, could you increase the intake by using more concentrated products rather than by increasing the rate of delivery?
Dr. Pichard: No, I doubt whether that's an option because it is very unlikely to be tolerated at much higher concentrations than we give at present.
Dr. Barbul: I couldn't agree with you more. Do you think this is the reason why there are so many wonderful efficacy data on parenteral feeding but such paucity of efficacy data with enteral feeding? We all struggle to set targets for intake and we think we're achieving them, but when we really look at the figures we see we are achieving only about 50% of the target.
Tolerance and Utilization of Enteral Nitrogen
Dr. Pichard: Obviously if you really want to achieve 100% of your target, you just prescribe TPN and it works. But of course this does not take account of the hazards. When things go well, TPN is very successful; when things turn bad, it's a disaster.
Dr. Barbul: The group in New Zealand has very convincingly shown that with immediate postoperative enteral feeds, where they only achieve about a 900-to 1000-kcal intake, there is a significant effect on collagen synthesis [6] . Maybe targets based on nutritional parameters are not really sacred. Perhaps we should be thinking more in terms of biological endpoints, and these may be achievable with lower intakes.
